The Efficacy of Sacubitril/Valsartan (ARNI) in Decreasing MortalityAmong Heart Failure Patients: A Systematic Review and Meta-Analysis
Sacubitril/Valsartan represents an effective therapeutic option for CHF, providing significant benefits in reducing mortality and morbidity compared with standard therapy.
Authors
- Hashim Talib Hashim (ORCID: https://orcid.org/0000-0001-6155-7302)
- Marwa Fadhil Alsaffar (ORCID: https://orcid.org/0000-0001-7037-4831)
- Abbas Kamil sh. Khalaf
- Ahmed Qasim Mohammed Alhatemi (ORCID: https://orcid.org/0009-0004-9076-8220)
- Zahraa I. Al-Anssari
- Wajeeh Hassan
- Zainab Ahmed Lateef
- Ahmed Dheyaa Al-Obaidi
- Kanchan Chaudhary (ORCID: https://orcid.org/0009-0002-6754-366X)
- Israa Al-ghuri
- Mohammedbaqer Ali Al-Ghuraibawi
- Muhammad Hassan Hafeez
- Vikash Kumar Karmani
Institutions
- Liaquat University of Medical & Health Sciences (PK)
- University of Baghdad (IQ)
- Thi Qar University (IQ)
- Allama Iqbal Medical College (PK)
- Shalamar Hospital (PK)
- Jinnah Sindh Medical University (PK)
- Alsalam University College (IQ)
- University of Kerbala (IQ)
- University of Warith Al-Anbiyaa
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- Current Cardiology Reviews
- Published
- 2026-03-04
- DOI
- https://doi.org/10.2174/011573403x375722251124114203
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00